MDT Medtronic Plc

Price (delayed)

$109.23

Market cap

$146.83B

P/E Ratio

33.2

Dividend/share

$2.24

EPS

$3.29

Enterprise value

$169.02B

Sector: Healthcare
Industry: Medical Devices
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Highlights

Medtronic's quick ratio has decreased by 30% YoY and by 9% from the previous quarter
MDT's debt is up by 16% since the previous quarter and by 9% year-on-year

Key stats

What are the main financial stats of MDT
Market
Shares outstanding
1.34B
Market cap
$146.83B
Enterprise value
$169.02B
Valuations
Price to earnings (P/E)
33.2
Price to book (P/B)
2.91
Price to sales (P/S)
5.25
EV/EBIT
39.23
EV/EBITDA
24.2
EV/Sales
6.05
Earnings
Revenue
$27.93B
EBIT
$4.31B
EBITDA
$6.98B
Free cash flow
$4.76B
Per share
EPS
$3.29
Free cash flow per share
$3.54
Book value per share
$37.5
Revenue per share
$20.81
TBVPS
$25.73
Balance sheet
Total assets
$93.91B
Total liabilities
$43.46B
Debt
$28.69B
Equity
$50.3B
Working capital
$11.42B
Liquidity
Debt to equity
0.57
Current ratio
1.87
Quick ratio
1.37
Net debt/EBITDA
3.18
Margins
EBITDA margin
25%
Gross margin
65.8%
Net margin
15.8%
Operating margin
14.2%
Efficiency
Return on assets
4.8%
Return on equity
8.7%
Return on invested capital
9.7%
Return on capital employed
5.3%
Return on sales
15.4%
Dividend
Dividend yield
2.05%
DPS
$2.24
Payout ratio
68.1%

MDT stock price

How has the Medtronic stock price performed over time

Financial performance

How have Medtronic's revenue and profit performed over time
Revenue
$27.93B
Gross profit
$18.36B
Operating income
$3.98B
Net income
$4.41B
Gross margin
65.8%
Net margin
15.8%
The operating income has decreased by 39% YoY and by 17% QoQ
The operating margin has declined by 33% year-on-year and by 14% since the previous quarter
MDT's gross profit is down by 14% year-on-year and by 6% since the previous quarter
MDT's net margin is up by 10% year-on-year but it is down by 4.8% since the previous quarter

Growth

What is Medtronic's growth rate over time

Valuation

What is Medtronic stock price valuation
P/E
33.2
P/B
2.91
P/S
5.25
EV/EBIT
39.23
EV/EBITDA
24.2
EV/Sales
6.05
The price to earnings (P/E) is 13% higher than the last 4 quarters average of 29.4
The EPS has declined by 8% since the previous quarter
The stock's price to book (P/B) is 21% more than its 5-year quarterly average of 2.4 and 3.9% more than its last 4 quarters average of 2.8
MDT's P/S is 28% higher than its 5-year quarterly average of 4.1 and 12% higher than its last 4 quarters average of 4.7
Medtronic's revenue has decreased by 9% YoY and by 3.4% from the previous quarter

Efficiency

How efficient is Medtronic business performance
The company's return on invested capital fell by 40% YoY and by 16% QoQ
The return on sales has declined by 30% year-on-year and by 13% since the previous quarter
MDT's return on assets is down by 8% since the previous quarter and by 2% year-on-year
Medtronic's return on equity has decreased by 7% QoQ

Dividends

What is MDT's dividend history
DPS
$2.24
Dividend yield
2.05%
Payout ratio
68.1%
Recent dividends

Financial health

How did Medtronic financials performed over time
The total assets is 116% greater than the total liabilities
The company's current ratio fell by 30% YoY and by 12% QoQ
Medtronic's quick ratio has decreased by 30% YoY and by 9% from the previous quarter
MDT's debt is 43% smaller than its equity
Medtronic's debt to equity has increased by 16% from the previous quarter and by 10% YoY
MDT's debt is up by 16% since the previous quarter and by 9% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.